Systematic literature review of SARS-CoV-2 seroprevalence surveys in Canada through April 2021
- PMID: 35919829
- PMCID: PMC9335354
- DOI: 10.1016/j.ijregi.2022.07.010
Systematic literature review of SARS-CoV-2 seroprevalence surveys in Canada through April 2021
Abstract
Objectives: To estimate the proportion of the population infected by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in Canada through April 2021, 16 months into the coronavirus disease 2019 (COVID-19) pandemic and 4 months after COVID-19 vaccines became available.
Methods: Publication databases, preprint servers, public health databases and the grey literature were searched for seroprevalence surveys conducted in Canada from 1 November 2019 to 10 July 2021. Studies were assessed for bias using the Joanna Briggs Checklist. Numbers of infections derived from seroprevalence estimates were compared with reported cases to estimate under-ascertainment ratios.
Results: In total, 12 serosurveys with 210,321 participants were identified. Three (25%) serosurveys were conducted at national level, one (8.3%) was conducted at provincial level, and eight (66.7%) were conducted at local level. All 12 serosurveys had moderate or high risk of bias. The proportion of the population infected by April 2021 was low (2.6%). The proportion of the population infected was higher in surveys of residents of long-term care facilities (43.0-86%), workers at long-term care facilities (22.4-32.4%), and workers in healthcare institutions (1.4-14%).
Conclusions: As of April 2021, the proportion of the population infected by SARS-CoV-2 was low in the overall population of Canada, but was high in healthcare facilities, particularly long-term care facilities, supporting the need for vaccines.
Keywords: Antibodies; COVID-19; Canada; SARS-CoV-2; Seroprevalence; Serosurvey.
© 2022 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
Figures



Similar articles
-
Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis.PLoS One. 2021 Jun 23;16(6):e0252617. doi: 10.1371/journal.pone.0252617. eCollection 2021. PLoS One. 2021. PMID: 34161316 Free PMC article.
-
Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys.JAMA Netw Open. 2021 Jan 4;4(1):e2033706. doi: 10.1001/jamanetworkopen.2020.33706. JAMA Netw Open. 2021. PMID: 33399860 Free PMC article.
-
Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era.Microbiol Spectr. 2022 Apr 27;10(2):e0033922. doi: 10.1128/spectrum.00339-22. Epub 2022 Apr 12. Microbiol Spectr. 2022. PMID: 35412385 Free PMC article.
-
Universal screening for SARS-CoV-2 infection: a rapid review.Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718. Cochrane Database Syst Rev. 2020. PMID: 33502003 Free PMC article.
-
Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis.EClinicalMedicine. 2021 Mar;33:100770. doi: 10.1016/j.eclinm.2021.100770. Epub 2021 Mar 8. EClinicalMedicine. 2021. PMID: 33718853 Free PMC article.
Cited by
-
[Effect of previous exposure to COVID-19, occurrence of spikes, and type of vaccine on the humoral immune response of institutionalized older adults].Cad Saude Publica. 2024 Oct 11;40(9):e00155023. doi: 10.1590/0102-311XES155023. eCollection 2024. Cad Saude Publica. 2024. PMID: 39417469 Free PMC article. Spanish.
-
Anti-SARS-CoV-2 Antibody Levels in a Cohort of Health Care Workers Before and After the Omicron Wave in Canada.J Assoc Med Microbiol Infect Dis Can. 2025 May 29;10(2):127-145. doi: 10.3138/jammi-2024-0029. eCollection 2025 Jun. J Assoc Med Microbiol Infect Dis Can. 2025. PMID: 40673053 Free PMC article.
-
SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron.Viruses. 2022 Oct 25;14(11):2336. doi: 10.3390/v14112336. Viruses. 2022. PMID: 36366432 Free PMC article.
References
-
- Atsma F, de Vegt F. The healthy donor effect: A matter of selection bias and confounding. Transfusion. 2011;51:1883–1885. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous